autosomal recessive limb-girdle muscular dystrophy type 2I
autosomal recessive limb-girdle muscular dystrophy type 2I
Explore linked clinical trials. Standard reference: MONDO:00117877 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I) | autosomal recessive limb-girdle muscular dystrophy type 2I | Active, not recruiting | Phase 3 | 2026-09-09 | NCT05775848 | |
| A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Disorders, Atrophic, autosomal recessive limb-girdle muscular dystrophy type 2A, autosomal recessive limb-girdle muscular dystrophy type 2I, hereditary disease, limb-girdle muscular dystrophy, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-26 | NCT05230459 | |
| Study of BBP-418 in Patients With LGMD2I | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Disorders, Atrophic, autosomal recessive limb-girdle muscular dystrophy type 2I, hereditary disease, limb-girdle muscular dystrophy, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Active, not recruiting | Phase 2 | 2026-07-21 | NCT04800874 | |
| Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9 | autosomal recessive limb-girdle muscular dystrophy type 2I | Active, not recruiting | Phase 3 | 2026-07-02 | NCT07678775 | |
| Long-Term Development of Muscular Dystrophy Outcome Assessments | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Emery-Dreifuss muscular dystrophy 2, autosomal dominant, Eye Diseases, Hereditary, Limb-girdle muscular dystrophy, type 2E, Malformations of Cortical Development, Group II, Muscular Disorders, Atrophic, Muscular Dystrophy, Limb-Girdle, Type 1C, Muscular Dystrophy, Limb-Girdle, Type 1E, Respiration Disorders, autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6), autosomal dominant limb-girdle muscular dystrophy type 1F, autosomal dominant limb-girdle muscular dystrophy type 1G, autosomal dominant limb-girdle muscular dystrophy type 1H, autosomal recessive limb-girdle muscular dystrophy type 2A, autosomal recessive limb-girdle muscular dystrophy type 2B, autosomal recessive limb-girdle muscular dystrophy type 2C, autosomal recessive limb-girdle muscular dystrophy type 2F, autosomal recessive limb-girdle muscular dystrophy type 2G, autosomal recessive limb-girdle muscular dystrophy type 2I, autosomal recessive limb-girdle muscular dystrophy type 2J, autosomal recessive limb-girdle muscular dystrophy type 2L, autosomal recessive limb-girdle muscular dystrophy type 2M, autosomal recessive limb-girdle muscular dystrophy type 2N, autosomal recessive limb-girdle muscular dystrophy type 2O, autosomal recessive limb-girdle muscular dystrophy type 2P, autosomal recessive limb-girdle muscular dystrophy type 2Q, autosomal recessive limb-girdle muscular dystrophy type 2T, autosomal recessive limb-girdle muscular dystrophy type 2U, autosomal recessive limb-girdle muscular dystrophy type 2W, autosomal recessive limb-girdle muscular dystrophy type 2X, autosomal recessive limb-girdle muscular dystrophy type 2Y, autosomal recessive limb-girdle muscular dystrophy type R18, cardiomyopathy, cardiovascular disorder, central nervous system malformation, cerebral cortical dysplasia, cobblestone lissencephaly, eye disorder, heart disorder, hereditary disease, inherited neurodegenerative disorder, limb-girdle muscular dystrophy, lissencephaly spectrum disorders, muscle tissue disorder, muscular dystrophy, muscular dystrophy-dystroglycanopathy, type A, musculoskeletal system disorder, myotonic dystrophy, myotonic syndrome, nervous system disorder, neurodegenerative disease, neuromuscular disease, respiratory system disorder, sarcoglycanopathy | Recruiting | Not stated | 2025-11-18 | NCT05989620 | |
| ATA-100 (Formerly GNT0006) Gene Therapy Trial in Patients With LGMDR9 | autosomal recessive limb-girdle muscular dystrophy type 2I | Active, not recruiting | Phase 1 | 2025-10-06 | NCT05224505 | |
| Clinical Trial Readiness for the Dystroglycanopathies | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Malformations of Cortical Development, Group II, Muscular Disorders, Atrophic, autosomal recessive limb-girdle muscular dystrophy type 2I, autosomal recessive limb-girdle muscular dystrophy type 2M, central nervous system malformation, cerebral cortical dysplasia, cobblestone lissencephaly, eye disorder, hereditary disease, lissencephaly spectrum disorders, muscle tissue disorder, muscular dystrophy, muscular dystrophy-dystroglycanopathy, type A, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Recruiting | Not stated | 2025-07-30 | NCT00313677 |